journal
MENU ▼
Read by QxMD icon Read
search

Journal of the American College of Cardiology

journal
https://read.qxmd.com/read/31277840/antithrombotic-agents-from-aspirin-to-doacs-in-coronary-artery-disease-and-in-atrial-fibrillation-part-i
#1
REVIEW
Freek W A Verheugt, Jurriën M Ten Berg, Robert F Storey, Thomas Cuisset, Christopher B Granger
For secondary prevention of coronary artery disease (CAD), oral antiplatelet therapy is essential. In case of coronary intervention, temporary dual antiplatelet therapy is mandatory as well. Recently, low-dose oral anticoagulation has entered the CAD arena. Atrial fibrillation (AF) is often seen in CAD and vice versa. In most patients stroke prevention in AF consists of oral anticoagulation. In many cases of CAD in patients with AF, anticoagulation has to be combined with antiplatelet agents (so called, dual pathway antithrombotic therapy)...
June 27, 2019: Journal of the American College of Cardiology
https://read.qxmd.com/read/31248701/2019-acc-aha-ase-key-data-elements-and-definitions-for-transthoracic-echocardiography-a-report-of-the-american-college-of-cardiology-american-heart-association-task-force-on-clinical-data-standards-writing-committee-to-develop-cardiovascular-endpoints-data
#2
Pamela S Douglas, Blase A Carabello, Roberto M Lang, Leo Lopez, Patricia A Pellikka, Michael H Picard, James D Thomas, Paul Varghese, Tracy Y Wang, Neil J Weissman, Rebecca Wilgus
No abstract text is available yet for this article.
June 20, 2019: Journal of the American College of Cardiology
https://read.qxmd.com/read/31136789/correction
#3
J M Khan, V C Babaliaros, A B Greenbaum, J R Foerst, S Yazdani, J M McCabe, G Paone, M H Eng, B G Leshnower, P T Gleason, M Y Chen, D D Wang, X Tian, A M Stine, T Rogers, R J Lederman
No abstract text is available yet for this article.
May 25, 2019: Journal of the American College of Cardiology
https://read.qxmd.com/read/31085320/a-percutaneous-permanent-carotid-filter-for-stroke-prevention-in-atrial-fibrillation-the-capture-trial
#4
Vivek Y Reddy, Petr Neuzil, Tom de Potter, Jan van der Heyden, Selma C Tromp, Benno Rensing, Eva Jiresova, Libor Dujka, Veronika Lekesova
BACKGROUND: High stroke risk atrial fibrillation patients unsuitable to oral anticoagulants (OAC) require other stroke prevention strategies. A novel permanent coil filter directly placed into both common carotid arteries (CCAs) was designed to capture emboli >1.4mm diameter. OBJECTIVES: In a multicenter, non-randomized, first-in-human clinical trial (CAPTURE), to determine the feasibility and safety of bilateral CCA filter placement. METHODS: Eligible patients had atrial fibrillation, CHA2 DS2 -VASc ≥ 2, OAC unsuitability, CCA size 4...
May 8, 2019: Journal of the American College of Cardiology
https://read.qxmd.com/read/31097258/home-based-cardiac-rehabilitation-a-scientific-statement-from-the-american-association-of-cardiovascular-and-pulmonary-rehabilitation-the-american-heart-association-and-the-american-college-of-cardiology
#5
Randal J Thomas, Alexis L Beatty, Theresa M Beckie, LaPrincess C Brewer, Todd M Brown, Daniel E Forman, Barry A Franklin, Steven J Keteyian, Dalane W Kitzman, Judith G Regensteiner, Bonnie K Sanderson, Mary A Whooley
Cardiac rehabilitation (CR) is an evidence-based intervention that uses patient education, health behavior modification, and exercise training to improve secondary prevention outcomes in patients with cardiovascular disease. CR programs reduce morbidity and mortality rates in adults with ischemic heart disease, heart failure, or cardiac surgery but are significantly underused, with only a minority of eligible patients participating in CR in the United States. New delivery strategies are urgently needed to improve participation...
May 7, 2019: Journal of the American College of Cardiology
https://read.qxmd.com/read/31078637/his-corrective-pacing-or-biventricular-pacing-for-cardiac-resynchronization-in-heart-failure
#6
LETTER
Gaurav A Upadhyay, Pugazhendi Vijayaraman, Hemal M Nayak, Nishant Verma, Gopi Dandamudi, Parikshit S Sharma, Moeen Saleem, John Mandrola, Davide Genovese, Roderick Tung
No abstract text is available yet for this article.
May 7, 2019: Journal of the American College of Cardiology
https://read.qxmd.com/read/31071413/surgery-is-not-associated-with-improved-survival-compared-to-medical-therapy-in-isolated-severe-tricuspid-regurgitation
#7
Andrea L Axtell, Vijeta Bhambhani, Philicia Moonsamy, Emma W Healy, Michael H Picard, Thoralf M Sundt, Jason H Wasfy
BACKGROUND: Patients with isolated tricuspid regurgitation (TR) in the absence of left-sided valvular dysfunction are historically managed nonoperatively. OBJECTIVES: To assess the impact of surgery for isolated TR, we compared survival for isolated severe TR patients who underwent surgery to those who did not. METHODS: A longitudinal echocardiography database was used to perform a retrospective analysis on 3,276 adult patients with isolated severe TR from November 2001-March 2016...
May 3, 2019: Journal of the American College of Cardiology
https://read.qxmd.com/read/31085321/pulsed-field-ablation-for-pulmonary-vein-isolation-in-atrial-fibrillation
#8
Vivek Y Reddy, Petr Neuzil, Jacob S Koruth, Jan Petru, Moritoshi Funosako, Hubert Cochet, Lucie Sediva, Milan Chovanec, Srinivas R Dukkipati, Pierre Jais
BACKGROUND: Catheter ablation of atrial fibrillation using thermal energies such as radiofrequency or cryothermy is associated with indiscriminate tissue destruction. During pulsed field ablation (PFA), sub-second electric fields create microscopic pores in cell membranes - a process called electroporation. Among cell types, cardiomyocytes have among the lowest thresholds to these fields, potentially permitting preferential myocardial ablation. OBJECTIVES: To determine whether PFA allows durable pulmonary vein (PV) isolation without damage to collateral structures...
April 29, 2019: Journal of the American College of Cardiology
https://read.qxmd.com/read/31296300/correction
#9
(no author information available yet)
No abstract text is available yet for this article.
July 16, 2019: Journal of the American College of Cardiology
https://read.qxmd.com/read/31296299/cardiovascular-biomarkers-after-metabolic-surgery-versus-medical-therapy-for-diabetes
#10
LETTER
Deepak L Bhatt, Ali Aminian, Sangeeta R Kashyap, John P Kirwan, Kathy Wolski, Stacy A Brethauer, Stanley L Hazen, Steven E Nissen, Philip R Schauer
No abstract text is available yet for this article.
July 16, 2019: Journal of the American College of Cardiology
https://read.qxmd.com/read/31296298/how-do-asians-fit-into-the-american-college-of-cardiology-s-diversity-and-inclusion-initiative
#11
Norman C Wang
No abstract text is available yet for this article.
July 16, 2019: Journal of the American College of Cardiology
https://read.qxmd.com/read/31296297/cardiac-mri-endpoints-in-myocardial-infarction-experimental-and-clinical-trials-jacc-scientific-expert-panel
#12
REVIEW
Borja Ibanez, Anthony H Aletras, Andrew E Arai, Hakan Arheden, Jeroen Bax, Colin Berry, Chiara Bucciarelli-Ducci, Pierre Croisille, Erica Dall'Armellina, Rohan Dharmakumar, Ingo Eitel, Rodrigo Fernández-Jiménez, Matthias G Friedrich, David García-Dorado, Derek J Hausenloy, Raymond J Kim, Sebastian Kozerke, Christopher M Kramer, Michael Salerno, Javier Sánchez-González, Javier Sanz, Valentin Fuster
After a reperfused myocardial infarction (MI), dynamic tissue changes occur (edema, inflammation, microvascular obstruction, hemorrhage, cardiomyocyte necrosis, and ultimately replacement by fibrosis). The extension and magnitude of these changes contribute to long-term prognosis after MI. Cardiac magnetic resonance (CMR) is the gold-standard technique for noninvasive myocardial tissue characterization. CMR is also the preferred methodology for the identification of potential benefits associated with new cardioprotective strategies both in experimental and clinical trials...
July 16, 2019: Journal of the American College of Cardiology
https://read.qxmd.com/read/31296296/evolving-the-hospital-readmissions-reduction-program-a-call-for-peace-happiness-and-improved-patient-centered-outcomes
#13
EDITORIAL
Adrian F Hernandez, Adam D DeVore
No abstract text is available yet for this article.
July 16, 2019: Journal of the American College of Cardiology
https://read.qxmd.com/read/31296295/evaluation-of-30-day-hospital-readmission-and-mortality-rates-using-regression-discontinuity-framework
#14
Rohan Khera, Yongfei Wang, Khurram Nasir, Zhenqiu Lin, Harlan M Krumholz
BACKGROUND: The Hospital Readmissions Reduction Program (HRRP) has been associated with reduced 30-day readmissions for acute myocardial infarction (AMI) and heart failure (HF). OBJECTIVES: The purpose of this study was to test whether this 30-day readmission reduction is a manifestation of practices that defer or avoid hospitalizations beyond the 30-day period. METHODS: At all U.S. hospitals under HRRP, the authors calculated daily readmission rates for elderly Medicare fee-for-service beneficiaries through day-60 post-discharge following a hospitalization for AMI and HF-the 2 target cardiovascular conditions-as well as pneumonia in July 2008 to June 2016...
July 16, 2019: Journal of the American College of Cardiology
https://read.qxmd.com/read/31296294/paclitaxel-eluting-devices-for-femoropopliteal-disease-drastic-advance-in-therapy-or-a-danger-to-our-patients
#15
EDITORIAL
John R Laird
No abstract text is available yet for this article.
July 16, 2019: Journal of the American College of Cardiology
https://read.qxmd.com/read/31296293/drug-eluting-balloon-versus-drug-eluting-stent-for-complex-femoropopliteal-arterial-lesions-the-drastico-study
#16
Francesco Liistro, Paolo Angioli, Italo Porto, Kenneth Ducci, Giovanni Falsini, Giorgio Ventoruzzo, Lucia Ricci, Alessia Scatena, Simone Grotti, Leonardo Bolognese
BACKGROUND: Drug-eluting technologies improve 12-month angiographic results of femoropopliteal (FP) interventions, but few data on the comparison between drug-coated balloons (DCBs) and drug-eluting stents (DES) are available. OBJECTIVES: The aim of this study was to compare, after balloon pre-dilation, a strategy of DCB followed by provisional self-expanding nitinol bare-metal stent implantation with a strategy of systematic DES implantation in patients at high risk for FP restenosis...
July 16, 2019: Journal of the American College of Cardiology
https://read.qxmd.com/read/31296292/enterococcus-faecalis-bacteremia-consider-an-echocardiography-but-consult-an-infectious-diseases-specialist
#17
EDITORIAL
Nuria Fernández-Hidalgo, Laura Escolà-Vergé
No abstract text is available yet for this article.
July 16, 2019: Journal of the American College of Cardiology
https://read.qxmd.com/read/31296291/prevalence-of-infective-endocarditis-in-enterococcus-faecalis-bacteremia
#18
Anders Dahl, Kasper Iversen, Niels Tonder, Nis Hoest, Magnus Arpi, Morten Dalsgaard, Mahtab Chehri, Lars L Soerensen, Soren Fanoe, Soeren Junge, Ulla Hoest, Nana Valeur, Trine K Lauridsen, Emil Fosbol, Thomas Hoi-Hansen, Niels E Bruun
BACKGROUND: Enterococcus faecalis is the third most frequent cause of infective endocarditis (IE). Despite this, no systematic prospective echocardiography studies have examined the prevalence of IE in patients with E. faecalis bacteremia. OBJECTIVES: This study sought to determine the prevalence of IE in patients with E. faecalis bacteremia. The secondary objective was to identify predictors of IE. METHODS: From January 1, 2014, to December 31, 2016, a prospective multicenter study was conducted with echocardiography in consecutive patients with E...
July 16, 2019: Journal of the American College of Cardiology
https://read.qxmd.com/read/31296290/doacs-in-patients-with-atrial-fibrillation-and-liver-disease-time-to-expand-the-safety-zone
#19
EDITORIAL
Eue-Keun Choi, So-Ryoung Lee
No abstract text is available yet for this article.
July 16, 2019: Journal of the American College of Cardiology
https://read.qxmd.com/read/31296289/edoxaban-versus-warfarin-in-patients-with-atrial-fibrillation-and-history-of-liver-disease
#20
Arman Qamar, Elliott M Antman, Christian T Ruff, Francesco Nordio, Sabina A Murphy, Laura T Grip, Norton J Greenberger, Ophelia Q P Yin, Youngsook Choi, Hans J Lanz, Michele F Mercuri, Eugene Braunwald, Robert P Giugliano
BACKGROUND: Patients with liver disease have increased risk of thrombosis and bleeding but are typically excluded from trials of direct oral anticoagulant agents. OBJECTIVES: This study evaluated the pharmacokinetics (PK), pharmacodynamics (PD), clinical efficacy and safety of edoxaban versus warfarin in patients with atrial fibrillation (AF) and history of liver disease. METHODS: ENGAGE AF-TIMI 48 (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis In Myocardial Infarction Study 48) was a randomized, double-blind trial comparing edoxaban with warfarin in patients with AF followed for 2...
July 16, 2019: Journal of the American College of Cardiology
journal
journal
20134
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"